Why the study?
Does preserved left ventricular systolic function affect five year mortality in patients with chronic heart failure?
Does preserved left ventricular systolic function affect five year mortality in patients with chronic heart failure?
This prospective cohort study aims to compare the five-year mortality between chronic heart failure patients with preserved versus impaired left ventricular systolic function.
HFpEF vs HFrEF 5-year mortality comparison needed; leaves open differential prognosis and management in chronic heart failure.
Chronic heart failure due to left ventricular systolic impairment is characterised by a poor prognosis and abnormalities of cardiac structure, autonomic and neurohumoral function, and fluid and electrolyte homoeostasis, all of which are thought to contribute to the pathophysiology of this condition. However, some studies have found that 30-50% of all patients with chronic heart failure have preserved left ventricular systolic function. 1 Despite this, the natural course of the condition in these patients is controversial, and their pathophysiological characterisation poor. As a result, optimum treatment strategies are unclear. We looked at five year mortality in patients recruited to a large cohort study of chronic heart failure, comparing those having impairment of left ventricular function with those having preserved function.
No takes yet. Share an insight, caveat, or question.
MacCarthy et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: